| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cd19-tcrz-41bb and cd22-tcrz-41bb car-t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymph[MeSHID:D008196] T-Lymphocyte[MeSHID:D013601] Hematopoietic Neoplasms[MeSHID:D019337] |
NA | phase 1/2 | unknown |
| cd19-tcrz-41bb and cd22-tcrz-41bb car-t cells | b-cell receptor cd22 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymph[MeSHID:D008196] T-Lymphocyte[MeSHID:D013601] Hematopoietic Neoplasms[MeSHID:D019337] |
NA | phase 1/2 | unknown |
| click here to return to the previous page | ||||||||